ガン免疫療法におけるインドレアミン2,3-二酸化酵素1:小分子抑制からPROTAC媒介による分解まで
Xiuyun Li1, Hao Meng1, Hefeng Wang1
1Infection and Microbiology Research Laboratory for Women and Children, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Shandong, China.
Frontiers in pharmacology
|September 2, 2025
まとめ
インドレアミン2,3-二酸化酵素1 (IDO1) は,トリプトファンを枯渇させ,キヌレニンを生成することによって,がん免疫を調節する. 次世代PROTAC技術は IDO1を完全に分解し 癌の免疫療法戦略を前進させています
科学分野:
- 腫瘍学
- 免疫学
- 代謝経路について
背景:
- インドレアミン2,3-二酸化酵素1 (IDO1) は,がんにおける重要な免疫代謝酵素である.
- IDO1はトリプトファンをキヌレニンに分解することで腫瘍の免疫抑制を促進します.
- これは,GCN2とAhR経路を通じて免疫抑制性腫瘍の微環境を作り出します.
研究 の 目的:
- 臨床的に研究されたIDO1阻害剤とそのプロフィールをレビューする.
- IDO1を標的とするPROTAC分解剤の臨床前可能性を評価する.
- IDO1を標的とするがん免疫療法の最適化に関する洞察を提供すること.
主な方法:
- 臨床試験における IDO1 阻害剤の体系的レビュー
- IDO1のためのタンパク質分解ターゲティングキメラ (PROTAC) 技術の分析
- 作用のメカニズムと治療の可能性の評価
主要な成果:
- 20種類以上の小分子IDO1阻害剤が臨床試験に参加しており,有効性は変動しています.
- PROTACsは標的を完全に破壊し,抑制よりも有意な進歩をもたらします.
- IDO1抑制戦略には,標的の関与とバイオマーカーの改善が必要です.
結論:
- IDO1はがんの免疫療法における重要な標的である.
- PROTAC技術は,IDO1を標的とするがん治療において,大きな希望を示しています.
- IDO1をターゲットとした戦略と患者の選択を最適化するためにさらなる研究が必要である.
関連する概念動画
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K


